282 filings
Page 4 of 15
8-K
88oi4r7fde6
26 Jun 20
Other Events
2:35pm
8-K
k98uizu1t0pp ul
11 Jun 20
Securities Purchase Agreement
4:53pm
8-K
67tprt ck5
6 May 20
WHEREAS, the Company desires to employ the Executive on the terms and conditions set forth herein; and
5:07pm
8-K
7c8xfw8 ywq
21 Apr 20
Securities Purchase Agreement
4:50pm
8-K
z8de5fe
26 Mar 20
Entry into a Material Definitive Agreement
5:20pm
8-K
jhvlh0 dvqqex8g2
19 Mar 20
Other Events
3:08pm
8-K
92h4nkywtpiil5 wh
9 Mar 20
Regulation FD Disclosure
4:22pm
8-K
j0mvhy
5 Mar 20
Other Events
3:24pm
8-K
vwhy3l2u
4 Mar 20
Agreement No. Option-20-044
9:05am
8-K
j8thp3jg b9rrs4
12 Feb 20
RespireRx Pharmaceuticals Inc. CEO Issues Progress and Status Report
9:20am
8-K
jarou iqar
3 Feb 20
RespireRx Pharmaceuticals Inc. Announces Appointment of Tim Jones to its Board of Directors
9:10am
8-K
tjcpv
30 Dec 19
Departure of Directors or Certain Officers
9:17am
8-K
yiz 38e7bd3t68q2f
18 Dec 19
First Amendment to Settlement Agreement and Release
4:30pm
8-K
a93xq1b0zugm2npbi19u
5 Nov 19
Securities Purchase Agreement
3:00pm
8-K
n291l5xa64d
28 Oct 19
Securities Purchase Agreement
5:21pm
8-K
b105j6h
9 Sep 19
Regulation FD Disclosure
5:15pm
8-K
5quu do7a0osb8x
27 Aug 19
Securities Purchase Agreement
4:33pm
8-K
njd26kmi
23 May 19
Securities Purchase Agreement
4:46pm
8-K
5hbsfxz1r3 n5608d9j
30 Apr 19
Securities Purchase Agreement
4:05pm
8-K
7ijk87h
5 Mar 19
Entry into a Material Definitive Agreement
4:05pm